Pfizer's low P/E (8.8x) hints at recovery potential as new drugs gain traction, offsetting patent cliffs.
DBX jumps 11.9% on strong earnings beat & billings growth, still below 52-week high.
eBay rejects Cohen's $55B bid; EBAY up 56% YTD, GME down 16%. High leverage risk.
SCHD lags growth ETFs but offers higher yields & quality metrics. AI stocks may shift focus.
NTRA's revenue jumps 39% but losses widen, sending shares down 12%. Volatile stock.
GEVO drops 10% on EPS/revenue miss, valuation now 35% below 52-wk high. High volatility persists.
Crypto bill eyes $200M SEC exemption & AML rules. Stablecoin rewards debated, impacting bank deposits.
Sponsored
Must Read